Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primates
Open Access
- 1 April 2020
- Vol. 38 (17) , 3313-3320
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of War
This publication has 24 references indexed in Scilit:
- Effect of Formaldehyde Inactivation on PoliovirusJournal of Virology, 2014
- Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4′-aminomethyl-trioxsalen) is highly immunogenic in miceHuman Vaccines & Immunotherapeutics, 2013
- The global distribution and burden of dengueNature, 2013
- Immunogenicity and protective efficacy of a psoralen-inactivated dengue-1 virus vaccine candidate in Aotus nancymaae monkeysVaccine, 2011
- Immunogenicity of a Psoralen-Inactivated Dengue Virus Type 1 Vaccine Candidate in MiceClinical and Vaccine Immunology, 2010
- A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue VirusJournal of Virology, 2008
- Fundamentals of the psoralen-based Helinx™ technology for inactivation of infectious pathogens and leukocytes in platelets and plasmaSeminars in Hematology, 2001
- A High Frequency of Sequence Alterations Is Due to Formalin Fixation of Archival SpecimensThe American Journal of Pathology, 1999
- Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus MonkeysThe Journal of Infectious Diseases, 1996
- Photochemical Inactivation of DNA and RNA Viruses by Psoralen DerivativesJournal of General Virology, 1978